{
  "abstract": "This large cohort study showed that nucleos(t)ide analogue therapy is beneficial for patients with hepatitis B e antigen (HBeAg)-positive infection (patients with immune tolerance (IT)) with high replication or impending phase transition.1 Several serious issues need further clarification and discussion.",
  "authors": [
    {
      "affiliations": [
        "Liver Research Unit, Chang Gung Memorial Hospital, Taipei, Taiwan"
      ],
      "name": "Chia-Ming Chu"
    },
    {
      "affiliations": [
        "Liver Research Unit, Chang Gung Memorial Hospital, Taoyuan, Taiwan"
      ],
      "name": "Yun-Fan Liaw"
    }
  ],
  "title": "Nucleos(t)ide analogue therapy for EASL immune-tolerant phase hepatitis B",
  "uid": "a8dbcba8-52af-503f-b45e-af1e2eea203c"
}